Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs

被引:183
作者
Gothwal, Avinash [1 ]
Khan, Iliyas [1 ]
Gupta, Umesh [1 ]
机构
[1] Cent Univ Rajasthan, Sch Chem Sci & Pharm, Dept Pharm, Bandarsindri Ajmer 305817, Rajasthan, India
关键词
cancer; hydrophilic corona; hydrophobic core; nanotechnology; polymeric micelles; O-SULFATE CHITOSAN; ACID) BLOCK-COPOLYMER; PHASE-II TRIAL; ANTITUMOR-ACTIVITY; GENEXOL-PM; CREMOPHOR-FREE; PACLITAXEL; DOXORUBICIN; SYSTEM; BIODISTRIBUTION;
D O I
10.1007/s11095-015-1784-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanotechnology, in health and medicine, extensively improves the safety and efficacy of different therapeutic agents, particularly the aspects related to drug delivery and targeting. Among various nano-carriers, polymer based macromolecular approaches have resulted in improved drug delivery for the diseases like cancers, diabetes, autoimmune disorders and many more. Polymeric micelles consisting of hydrophilic exterior and hydrophobic core have established a record of anticancer drug delivery from the laboratory to commercial reality. The nanometric size, tailor made functionality, multiple choices of polymeric micelle synthesis and stability are the unique properties, which have attracted scientists and researchers around the world to work upon in this opportunistic drug carrier. The capability of polymeric micelles as nano-carriers are nowhere less significant than nanoparticles, liposomes and other nanocarriers, as per as the commercial feasibility and presence is concerned. In fact polymeric micelles are among the most extensively studied delivery platforms for the effective treatment of different cancers as well as non-cancerous disorders. The present review highlights the sequential and recent developments in the design, synthesis, characterization and evaluation of polymeric micelles to achieve the effective anticancer drug delivery. The future possibilities and clinical outcome have also been discussed, briefly.
引用
收藏
页码:18 / 39
页数:22
相关论文
共 123 条
[1]   A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer [J].
Ahn, Hee Kyung ;
Jung, Minkyu ;
Sym, Sun Jin ;
Shin, Dong Bok ;
Kang, Shin Myung ;
Kyung, Sun Young ;
Park, Jeong-Woong ;
Jeong, Sung Hwan ;
Cho, Eun Kyung .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) :277-282
[2]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[3]  
[Anonymous], 2010, CANC THER
[4]  
Bae Y, 2005, MOL BIOSYST, V1, P242, DOI 10.1039/b500266d
[5]   Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38 [J].
Bala, Vaskor ;
Rao, Shasha ;
Boyd, Ben J. ;
Prestidge, Clive A. .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :48-61
[6]  
Bhadra D, 2002, PHARMAZIE, V57, P5
[7]   β-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpres sing tumor cells [J].
Blanco, Elvin ;
Bey, Erik A. ;
Dong, Ying ;
Weinberg, Brent D. ;
Sutton, Damon M. ;
Boothman, David A. ;
Gao, Jinming .
JOURNAL OF CONTROLLED RELEASE, 2007, 122 (03) :365-374
[8]   Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel [J].
Burt, HM ;
Zhang, XC ;
Toleikis, P ;
Embree, L ;
Hunter, WL .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :161-171
[9]   Progress of drug-loaded polymeric micelles into clinical studies [J].
Cabral, Horacio ;
Kataoka, Kazunori .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :465-476
[10]   TOXICOLOGY OF A SERIES OF PHTHALATE ESTERS [J].
CALLEY, D ;
AUTIAN, J ;
GUESS, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (02) :158-&